Spotlight Review

BCR–ABL: a multi-faceted promoter of DNA mutation in chronic myelogeneous leukemia

• B A Burke
• M Carroll

Choosing the best treatment strategy for chronic myeloid leukemia patients resistant to imatinib: weighing the efficacy and safety of individual drugs with BCR-ABL mutations and patient history

• E Jabbour
• A Hochhaus
• H M Kantarjian

International Myeloma Working Group molecular classification of multiple myeloma: spotlight review

• R Fonseca
• P L Bergsagel
• H Avet-Loiseau

Proteasome inhibitors in the treatment of multiple myeloma

• J J Shah
• R Z Orlowski

The use of novel agents in the treatment of relapsed and refractory multiple myeloma

• J P Laubach
• A Mahindra
• P G Richardson

Harmonization of molecular monitoring of CML therapy in Europe

• M C Müller
• N C P Cross
• A Hochhaus

The molecular characterization and clinical management of multiple myeloma in the post-genome era

• Y Zhou
• B Barlogie
• J D Shaughnessy Jr

Chronic myeloproliferative diseases with and without the Ph chromosome: some unresolved issues

• J M Goldman
• A R Green
• A M Vannucchi

Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic/racial groups: support for genetic factors in pathogenesis

• O Landgren
• B M Weiss

Class effects of tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia

• F J Giles
• M O'Dwyer
• R Swords

Deletion 5q in myelodysplastic syndrome: a paradigm for the study of hemizygous deletions in cancer

• B L Ebert

Chromatin maps, histone modifications and leukemia

• T Neff
• S A Armstrong

Genomic approaches to small molecule discovery

• K Stegmaier

Genome-wide profiling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions

• C G Mullighan
• J R Downing

Toward a systems biology approach to investigate cellular networks in normal and malignant B cells

• K Basso

Role of autologous and allogeneic stem cell transplantation in myeloma

• W I Bensinger

Genomic tools for dissecting oncogenic transcriptional networks in human leukemia

• T Palomero
• A A Ferrando

The role of microRNA in human leukemia: a review

• S Yendamuri
• G A Calin

Pathogenesis of myeloma bone disease

• G D Roodman

International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

• A Dispenzieri
• R Kyle
• B G M Durie